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Experiments on the inhibiting effect of hunian and sheep red blood cell ex- 
tracts on the hemagglutinating action of mumps and influenza viruses have been 
described in a  previous report (1).  Results were presented which suggested 
that the inhibiting agent found in these red cell extracts was a derivative of, or 
identical with, the material which in the intact cell constitutes the receptor site 
for the virus in the hemagglutination reaction.  These results consisted partly 
in a  demonstration that, in the systems studied, the species specificity of the 
inhibition reaction paralleled that of the hemagglutination reaction.  Thus it is 
known that influenza (PR8) virus will agglutinate human and chicken red cells, 
but not sheep cells; and that mumps virus will agglutinate all three types of red 
cells.  It was found that the human red cell extracts inhibited the agglutination 
of human and chicken cells by influenza virus; and that of human, chicken, and 
sheep red cells by mumps virus.  Extracts of sheep ceils,  however, inhibited 
the agglutination of sheep cells by mumps virus, but did not inhibit agglutina- 
tion of human and chicken cells by influenza virus.  Further support for the 
view above mentioned was provided by the discovery that in a mixture of virus 
and inhibitor at 37°C. the latter was inactivated, just as is the receptor of intact 
cells under similar conditions in the elution phenomenon described by Hirst (2). 
Recently three other laboratories have reported interesting data in relation to the 
effect of various tissue and cell extracts and other substances  on virus hemagglutina- 
tion and multiplication.  Friedewald, Miller, and Whafley (3) described the hemag- 
glutination-inhibiting  effects of saline extracts of various human and animal tissues 
and red cells.  HorsfaU and McCarty (4)  produced evidence  to show that  certain 
bacterial and plant polysaccharides seem capable of interrupting the multiplication of 
PVM virus in mouse lung.  The intrapulmonary multiplication  of virus was reflected 
by a rise in hemagglutination titer of triturated infected mouse lung.  Administration 
of the polysaccharides  diminished or prevented this increase in titer after infection. 
Green and Woolley (5) have demonstrated the inhibitory effect of various animal and 
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plant polys~ccharides on the hem~gglutination  of chicken red cells by influenza PR8 
virus, and on the multiplication  of the same virus in the chicken embryo. 
The inhibitor previously reported from this laboratory was designated as a 
lipid extract of red cells.  The present report deals with further experiments on 
methods of preparation of the soluble inhibitor, on its partial purification, and 
on some chemical properties of the most active preparations that we have thus 
far obtained. 
EXPERIMENTAL 
Assay.--For assay purposes one unit of inhibitor was designated as that amount of material 
which would completely inactivate two minimal hemagglutinating doses of influenza virus, 
strain PR8.  The minimal hemagglutination dose was previously determined by titration as 
the smallest amount of virus which would agglutinate 0.1 cc. of 2.5 per cent cells in a  final 
volume of 0.5 co.  Unless otherwise stated, human group O cells and chick embryo allantoic 
fluid infected with PR8 influenza virus were used in the assays.  In the actual test 0.2 ml. of 
twofold serial dilutions of the extract to be tested was mixed with two minimal hemagglutinat- 
ing doses of virus contained in 0.2 ml. of saline buffered to pH 7.4 by addition of 10 per cent of 
0.15 molar phosphate buffer.  The mixture was kept at 4°C. for one-half hour and then 0.1 
ml. of a  2.5 per cent suspension of red cells in buffered saline was added, the mixture was 
shaken, and the cells were allowed to settle in the cold room.  The degree of agglutination was 
read by the pattern of the sedimented red cells after the method of Salk (6).  The titer repre- 
sents the reciprocal of the highest dilution of inhibitor showing complete absence of aggluti- 
nation. 
Extractlon of Inhibitor  from Red Cdls.--The first step was the conversion of cells  I to stroma,  s 
In earlier experiments the inhibitor was extracted from pools containing only group O cells. 
It is therefore evident that although it has been reported that blood group specific substance A 
exerts an inhibitory effect on hemagglutination by PR8 virus (5), the inhibitor under considera- 
tion is not the A or B  antigen.  This is further substantiated with respect to the A antigen 
by the fact that a highly purified specimen of group A substance from hog stomach  2 did not 
inhibit hemagglutination in a concentration of 1 rag. per cc.  It is also of interest that a prepa- 
ration of hog's stomach group O substance* did not inhibit hemagglutination at a concentration 
of 250 gamma per cc.  Friedewald (3) has also reported group A substance to be inactive as an 
inhibitor of chicken cell agglutination by influenza virus.  Owing to the ditficulty of securing 
adequate amounts of blood the later experiments were done with pools of all the types.  There 
was no significant difference in the amount or quality of extractable inhibitor obtained. 
In the earlier experiments the cells were washed three times with saline.  Since inhibitor 
material from unwashed cells was the same with respect to yield and behavior as that obtained 
from washed ceils, and since samples of pooled plasma showed no inhibitor extractable by the 
method outlined below, this tedious step was omitted in later preparations. 
The stroma was prepared after the method of Jorpes (7).  The packed cells were lysed by 
the addition of ten volumes of cold (5°C.) distilled or tap water, and the pH was brought to 5.6 
by the addition of I per cent HCI or acetate buffer pH 4.0 (700 ml. 10 ~ HAC, 200 ml. 7 M  NaAC, 
1 Cells and stroma were kindly supplied by the Antitoxin and Vaccine Laboratory, Massa- 
chusetts Department of Public Health, and by the Sharp and Dohme Company, Glenolden, 
Pennsylvania. 
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400 ml. distilled water).  The stroma settled out in a thick curd which was separated in the 
Sharpies  centrifuge.  The  pink  precipitate was  diluted  with  distilled water  to  a  volume 
roughly one-fifth that of the original, packed red cells, and the pH of the thick fluid was brought 
to 7.1-7.2 by the addition of 0.5 ~ NaOH with vigorous stirring. 
Calvin ctal.  (8) have shown that  stroma prepared as described consists of 
two fractions,  elinin  and  stromatin,  separable  by high  speed centrifugation 
over a pH range of 7.5 to 7.8.  It was of interest to determine which of these 
two fractions carried the inhibitory activity. 
Stroma was suspended in buffered saline pH 7.4 to give a pinkish opalescent solution.  On 
spinning this suspension  at  18,000 ~.v.u.  for 30  minutes, the elinin was found as a pinkish 
grey pellet on the bottom of the tube.  The clear supernatant stromatin solution was pipetted 
off, the elinin was resuspended in the original volume of buffered saline, and the two solutions 
were assayed for activity. 
The titer of the stromatin solution was less than twenty, while that of the 
elinin  suspension was  2500.  Obviously the  activity is  associated with  the 
elinin fraction. 
Various attempts to resolve the eUnin particles into soluble components with 
preservation of activity were unsuccessful until finally the fact that Calvin et al. 
had reported it to be a lipoprotein suggested the use of the McFariane (9) pro- 
cedure for dissociating  lipoproteins.  This  consisted of alternate freezing and 
thawing of an aqueous suspension or solution of the material in the presence of 
diethyl ether.  The procedure when apphed to stroma yielded the inhibitor in 
an ether-soluble form. 
Whole stroma paste, pH 7.0, was distributed in 70 ml. amounts into 250 ml. bottles.  One 
and one-half to two volumes of per0xide-free ether were added to each bottle, which was then 
stoppered  and shaken  vigorously until an emulsion had  formed.  The unstoppered  bottles 
were then placed in a dry ice box until the emulsion was frozen.  After thawing, the bottles 
were stoppered, shaken vigorously, centrifuged, and the ether was then siphoned off.  Fresh 
ether was added, and the procedure was repeated six times.  On further extraction the yield of 
ether-soluble active material decreased although the inhibitor content of the stroma was not 
entirely exhausted.  Similar results were obtained in the extraction of lung tissue (Fig. 1). 
The combined paleyellow  ether solutions wereevaporated in ~acuo  under a stream of COs to a 
light brown mud which was kept under suction until most of the water was removed.  This was 
then thoroughly triturated with acetone (200 ml. per liter of starting stroma suspension)  and 
the supernatant  was separated by eentrifugation and decantation.  The extraction was re- 
peated two or three times until the acetone washings were colorless.  The same process was 
repeated with 95 per cent alcohol, using approximately 75 ml. of alcohol per liter of stroma for 
each extraction, until the alcohol washings were colorless.  It was found that not only was all 
the activity left in the acetone- and alcohol-insoluble  fraction, but that the inhibitory titer was 
actually increased by the passage into the acetone and alcohol of some material which antago- 
nized the inhibitor (Table I).  This antagonistic effect is probably due to the action of some 
component of the acetone- and alcohol-soluble  fraction on the cells, since this fraction, when 
suspended in saline, caused agglutination of the cells in the absence of virus. 
Following the acetone extraction, the residue remained in the form of a light brown dry 
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A, batch 14.  Residue of I00 ml. ether extract resuspended in 6 ml. saline. 
B, batch 14.  Residue of 100 ml. ether extract treated with acetone and alcohol and re- 
suspended in 6 ml. saline. 
C, batch 28.  Residue of 100 ml. ether extract resuspended in 3 ml. saline. 
D, batch 28.  Residue of 100 ml. ether extract treated  with acetone and re.suspended in 
3  ml.  saline. 
E, batch 28.  Residue of 100 ml. ether extract treated with acetone and alcohol  and re- 
suspended in 3 ml. saline. 
convenient to treat the alcohol residue once again with acetone to obtain the active insoluble 
material in the powdered form.  Activity at this point was about 0.1 unit per gamma, and the 
yield averaged 2 to 3 gin. per liter of original stroma.  This powder was suspended in chioro- P.  M.  DEBURGH~ P.-C.  YU~  C.  HOWE~ AND  M.  BOVARNICK 
form overnight, then filtered through a sintered glass filter of medium porosity, washed, and 
dried.  A considerable amount of substance, usually about 50 per cent, dissolved in chloroform 
to give a dark brown solution, and approximately 15 per cent of the activity was often found 
in this soluble fraction.  The chloroform-insoluble brown powder contained most of the in- 
hibitor and its activity was of the order of 0.16 unit per gamma. 
The active material was water-soluble and could be extracted almost completely by allowing 
the powder to soak in water overnight in the refrigerator, or more rapidly by heating an aque- 
ous suspension of the powder at 50°C. for 20 to 30 minutes in a water bath.  On centrifuging 
the water-insoluble material at 18,000  R.P.~.  (25,000 g) in the high speed angle head centri- 
fuge for 30 minutes, clear, light brown aqueous solutions were obtained.  The activity of these 
solutions was of the order of 1.25 units per gamma of dry weight.  The active solutions gave 
a  positive Moliseh test and contained 7 per cent N.  The active material was apparently a 
substance of high molecular weight as it was non-dialyzable.  It was sedimentable in the 
ultracentrifuge at 200,000 to 240,000 g but was obviously impure, as the solution showed sev- 
eral components in the analytical ultracentrifuge.  About one-quarter of the material appeared 
to be a polydisperse fraction sedimenting very readily in the ultracentrifuge (sedimentation 
constants greater than 15 S).  Slightly more than half of it sedimented fairly uniformly, with 
sedimentation constants of 10 to 12 S.  The remainder was found in two minor components 
sedlmenting more slowly.  The active component was in the more rapidly sedlmenting frac- 
tions, and probably in the one coming down first.  This is only a  tentative conclusion as a 
clear separation of the two most rapidly sedlmenting fractions was not achieved.  Further 
purification of the fractions was not attempted since it was found possible to prepare decidedly 
more active material by another method, as follows:-- 
Preparation of Ctdoroform-Solubl¢ Mat~riol.--The freezing and thawing of the stroma-ether 
mixture was cumbersome, and a more convenient method of extraction was desired.  This was 
achieved by heating a neutral stroma paste containing a few per cent of ether at 70°C.  for 15 
minutes.  The mixture was cooled to room temperature afterwards and extracted with ap- 
proximately 3 to 4 volumes of ether, letting it remain at room temperature for 24 hours with 
frequent shaking.  Occasionally a  relatively stable emulsion was formed on shaking, which 
broke only on addition of more ether, or after prolonged standing.  The extraction was re- 
peated three times.  Further extractions resulted in decreasing amounts of activity. 
After removing the ether by distillation in va~uo the residue was dried and treated with 
acetone and alcohol as previously described.  At this point it was found that the activity lay 
in the insoluble light brown residual powder as before, but that, in contrast with the findings 
at the corresponding stage in the previous methods of preparation, this powder was almost 
completely soluble in chloroform.  On treating it with this solvent, there remained a  slight 
amount of insoluble brown gum, possessing some activity, which was removed by filtration 
through a sintered glass funnel.  The resulting clear, amber-colored fluid contained about 90 
per cent of the activity. 
Addition of seven volumes of acetone to the filtrate gave a  yellow, flocculent precipitate 
containing all of the activity.  After decanting the supernatant the precipitate was dissolved 
in a minimal amount of chloroform and one and one-half volumes of acetone was added.  A 
light flocculent precipitate separated out.  This contained 80 per cent of the activity. A mod- 
erate amount of dark brown impurity remained in the supernatant soluble portion, which was 
decanted after centrifugation.  The precipitate was redissolved in a minimal amount of chloro- 
form and reprecipitated with one and one-half volumes of acetone.  It dried  to an amber- 
colored solid which slowly dissolved in water to give a  ropy solution.  The activity of this 
solution was approximately 0.3 unit per gamma.  It contained lipid, as evidenced by the 
appearance after a short period of hydrolysis of an acid-insoluble, ether- and alkali-soluble oil. 
There was very little of this lipid however, and no substance possessing activity could be ex- 
tracted from the untreated, aqueous solution, on shaking with ether. 6  VIRUS HEMAGGLUTINATION IN~LI~ITOR 
The marked difference in chloroform solubility between the inhibitor solution 
obtained by the first and second of the methods described was of some interest, 
since it presented the possibility that two different substances were involved. 
However, it was found that the chloroform-soluble inhibitor could be converted 
into the chloroform-insoluble form by freezing and thawing an aqueous solution 
in the presence of ether and a high partial pressure of carbon dioxide.  Without 
this last the conversion was not effected.  It was also found that ether extrac- 
tion of the thoroughly dried material for 5 or 6 days at room temperature was 
partially effective in converting the powder to the chloroform-insoluble form. 
It seems likely that there was a lipid complex involved, the dissociation of which 
was subject to a pH effect.  This possibility was supported by one experiment 
in which it was found that conversion of the chloroform-soluble active material 
to  the  chloroform-insoluble form had  occurred after evaporation of a  small 
amount of the former to dryness by means of a stream of CO~.  The point, how- 
ever, has not been thoroughly investigated. 
Conversion of the Cldoroform-Sduble to the Insoluble Form.--A 0.390 gin. sample of chloro- 
form-soluble powder containing 125,0G0 units of activity was dissolved in 10 ml. of water and 
shaken with an approximately equal volume of ether.  No color went into the ether solution. 
The mixture was frozen and thawed under the conditions noted above.  On shaking after each 
thaw the ether layer was seen to become increasingly colored.  Following  the sixth thaw the 
ether was siphoned off and the water layer was repeatedly extracted with portions of ether un- 
til no more color went into the ether layer.  At this point the water layer was faintly straw- 
colored.  The water was removed by lyophilization, the residue was extracted with ether, 
chloroform, and petroleum ether, and dried, providing an almost white powder.  On resus- 
pending in 4 ml. of water, this powder went slowly  into solution after swelling into jelly-like 
particles.  A small amount of water-insoluble material was separated by centrifugation.  The 
clear viscous supernatant had a solid content of 12.0 rag. per ml., and had an activity of 2.5 
units per gamma against both mumps and PR8 viruses. 
The nitrogen content of this material, determined by a micro modification of the Nessler 
method (10) was 2.6 per cent.  It gave a positive ninhydrin test.  There  was no inactiva- 
tion on prolonged shaking with chloroform.  A quantitative determination showed no glu- 
cosamine to be present.  8  Further information on the nature of the nitrogenous component 
will await the preparation of more material.  There was no detectable phosphorous present 
in a 100 gamma sample. 
The material contained carbohydrate as evidenced by the presence of a posi- 
tive  Molisch  test.  The  quantitative orcinol test  for  pentoses  (II)  and the 
Dische test (12) for uronic acids were completely negative when assayed on 100 
gamma samples.  Under the  conditions used  I0  gamma  control samples  of 
xylose and Type IIl pneumococcus polysaccharide showed definite color.  The 
unhydrolyzed material gave a  reducing value of I  per cent (as glucose) by the 
Malmros modification of the Folin-Wu method for glucose (13).  On hydrolysis 
s This determination was kindly performed by Mr. Cava through the courtesy of Dr. Karl 
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the reducing sugar, determined as glucose equivalents, was found to be 48 per 
cent.  The maximum reducing value on hydrolysis with 2 ~ HC1 was found to 
occur in 1 hour, after which time it slowly decreased.  The inhibitor is ex- 
tremely labile to acid hydrolysis, being completely inactivated by treatment 
with 0.1 N HC1 for 5 minutes and 75 per cent inactivated by 0.C01 N HC1 for 10 
minutes in a boiling water bath.  One-thousandth normal NaOH at 100°C. for 
10 minutes caused no loss of activity.  A slight amount of insoluble material 
appeared on acid hydrolysis but the nature of this has not yet been investigated. 
A 1 per cent solution showed no measurable optical activity in a 1 dm. tube. 
This preparation was completely sedimentable in the analytical ultracentri- 
fuge but showed no sharp peak, behaving as a  polydisperse material with a 
minimum sedimentation constant of about 20.  This bears out the previously 
described results obtained with material in which it was indicated (but not 
clearly demonstrated) that the active component of this impure preparation 
was in the most rapidly sedimentable fraction. 
These purified inhibitor solutions were readily inactivated by virus.  In one 
experiment, 12,000 units of hlhibitor were inactivated by 300 hemagglutinating 
units of PR8 virus in 16 hours at room temperature with recovery of 30 per cent 
of the activity of the virus.  In the absence of the virus the inhibitor proved 
stable in watery solution at room temperature. 
DISCUSSION 
From the above data it is probable that the water-soluble, chloroform-insolu- 
ble  inhibitor is polysac~haride in nature.  This is not surprising,  especially 
when  considered  in  connection  with  the  previously mentioned findings of 
Horsfall, Woolley, and the still earlier reports of the inhibitory effects of poly- 
saccharides on bacteriophage (14) and on plant viruses (15).  Whether or not 
it is a complex protein or lipopolysaccharide it is impossible to say until further 
information is available on the state of purity of the active inhibitor and the 
chemical nature of its structural components.  It is evident that the chloro- 
form-soluble form of the inhibitor is associated with the presence of lipid mate- 
rial.  The conditions under which the lipid can be separated from the chloro- 
form-soluble active material indicate the possibility of a complex consisting of 
lipid and water-soluble, chloroform-insoluble inhibitor.  There are, of course, 
many known types of [ipoprotein and lipopolysaccharide complexes, and the 
nature and stability of the binding forces of these complexes show wide varia- 
tion.  It is possible that the active ether- and chloroform-soluble substance 
represents material that is less degraded than the water-soluble inhibitor, and it 
might, therefore, be a closer approximation to the natural state of the receptor 
as it exists in the red cell.  On the other hand, the possibility exists that the 
association of lipid and inhibitor, responsible for the chloroform solubility of the 
latter, is merely an artifact caused by the method of preparation.  Further in- VIRUS  HEM.AGGLUTINATION IN~IIBITOR 
vestigations should reveal more precisely the nature and characteristics of the 
material under consideration. 
It is of interest that our inhibitor is more active in preventing hemagglutina- 
tion than any of the numerouspolysacchaxides from various sources and the other 
materials tried by Woolley.  His most active preparations gave almost  com- 
plete inhibition of agglutination in concentrations of approximately 100 gamma 
per ml.  In a roughly comparable test our most active material gave complete 
inhibition, that is "0 or trace" of agglutination by Woolley's criteria, in a con- 
centration of 1.1 gamma per ml. 
Friedewald and collaborators also described the preparation of inhibitor in 
high titer by a saline extraction of human red cells.  In some experiments on 
specificity of inhibition, and elution of virus from inhibitor, they obtained data 
similar to our results already described (1).  They also arrived at the conclusion 
that the active material in the extracts represented the receptor substance of 
the red cell.  Their active extracts were prepared by lysing red cells in a Waxing 
blendor followed by centrifugafion of the mixture at 3,000 g.I,.~.  It would be 
of interest to know whether these extracts represent a  soluble inhibitor or a 
suspension of finely divided stroma (elinin).  In our experience elinin prepared 
by hemolysis of red cells remained suspended, with retention of inhibitor activ- 
ity, after centrifugation at 3,000 ~.I,.M. at pH 7.0; but it was sedimented at 
18,000 R.P.M. for 20 minutes to the extent of 90 per cent as estimated by the 
disappearance of inhibitor activity in the supernatant. 
Friedewald and collaborators describe the preparation of active extracts from 
various animal and human tissues, and raise the question as to the identity of 
tissue and red cell inhibitor.  In this connection it is of interest that although 
we have been able to obtain from human lung an ether-soluble inhibitor, we 
have not been able to find similar material in human liver, kidney, or serum. 
This and  various other  biological properties of the  inhibitor substances  are 
under investigation. 
SUMMARY 
Methods have been described for the extraction and purification of an agent 
inhibiting the hemagglutination of red cells by influenza  (PR8)  and mumps 
viruses.  Human red cells have served as the chief source of the inhibitor but 
the latter has also been found in human lung. 
The active extracts have been purified to the extent that 0.1 gamma of mate- 
rial suffices to inhibit one hemagglutinating dose of virus.  Incomplete chemical 
characterization of the most highly purified fractions available indicates the 
presence of 2.6 per cent nitrogen, at least 50 per cent of polysaccharide, and no 
phosphorus.  In the ultracentrifuge the purified preparation behaves as a poly- 
disperse macromolecular substance. 
The active material can be obtained from red cell stroma in an ether- and P. M.  DEBURGH, P.-C.  YU, C. HOWE, AND M.  BOVARRICK 
chloroform-soluble form which, on further treatment, can be converted into 
chloroform-insoluble material.  It is possible that the former represents more 
closely the virus receptor as it exists in the red cell. 
The purified inhibitor is inactivated on incubation with the virus at 37°C. 
The nature of this effect is being investigated. 
We are indebted to Miss P. M. Becker and Mr. Charles C. Gordon for ultracentrifuge 
analyses  which  were  performed  through the kindness  of Dr. J. L. Onc.ley  and in his laboratory. 
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